59.65
0.25%
0.15
시간 외 거래:
59.65
전일 마감가:
$59.50
열려 있는:
$59.58
하루 거래량:
437.99K
Relative Volume:
0.28
시가총액:
$2.33B
수익:
-
순이익/손실:
$-54.42M
주가수익비율:
-23.38
EPS:
-2.5513
순현금흐름:
$-50.87M
1주 성능:
+0.13%
1개월 성능:
+64.69%
6개월 성능:
+179.06%
1년 성능:
+980.62%
롱보드 파마 Stock (LBPH) Company Profile
명칭
Longboard Pharmaceuticals Inc
전화
619-592-9775
주소
4275 EXECUTIVE SQUARE, LA JOLLA
롱보드 파마 Stock (LBPH) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-10-24 | 재개 | Cantor Fitzgerald | Overweight |
2023-04-27 | 개시 | B. Riley Securities | Buy |
2021-04-07 | 개시 | Evercore ISI | Outperform |
2021-04-06 | 개시 | Cantor Fitzgerald | Overweight |
2021-04-06 | 개시 | Citigroup | Buy |
2021-04-06 | 개시 | Guggenheim | Buy |
모두보기
롱보드 파마 주식(LBPH)의 최신 뉴스
Vanguard Group Inc's Strategic Acquisition in Longboard Pharmace - GuruFocus.com
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Position Increased by Emerald Advisers LLC - MarketBeat
Longboard Pharmaceuticals (NASDAQ:LBPH) Hits New 1-Year High – Here’s What Happened - Defense World
Longboard Pharmaceuticals (NASDAQ:LBPH) Reaches New 52-Week HighShould You Buy? - MarketBeat
Longboard Pharmaceuticals stock soars to all-time high of $59.95 - Investing.com
Longboard Pharmaceuticals stock soars to all-time high of $59.95 By Investing.com - Investing.com Australia
Longboard Pharmaceuticals Inc options imply 0.8% move in share price post-earnings - TipRanks
LONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc.LBPH - Business Wire
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of “Hold” by Analysts - Defense World
Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal - MSN
(LBPH) Trading Signals - Stock Traders Daily
Longboard Pharmaceuticals stock soars to all-time high of $59.48 By Investing.com - Investing.com Australia
Longboard Pharmaceuticals (NASDAQ:LBPH) Hits New 1-Year HighStill a Buy? - MarketBeat
Longboard Pharmaceuticals stock soars to all-time high of $59.48 - Investing.com India
$DRUG 5,900% Weekly Surge Turns Attention. Cybin ($CYBN) Rallying 23% This Week In Anticipation For Major Milestones - FinanceFeeds
Longboard Pharmaceuticals (NASDAQ:LBPH) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio? - Benzinga
The week in pharma: action, reaction and insight – week to October 19 | Pharmaceutical | The Pharmaletter - The Pharma Letter
Longboard Pharmaceuticals’ stock soars amid Lundbeck’s $2.6 billion deal to acquire the company - MSN
Longboard Pharmaceuticals Stock Soars 51%. It’s Being Bought for $2.6 Billion. - MSN
Longboard soars as Lundbeck to buy company for equity value of $2.6B - MSN
Longboard Pharmaceuticals Strikes $2.6 Billion Deal to Be Acquired by Lundbeck - MSN
SG Americas Securities LLC Buys Shares of 10,514 Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump - MSN
Taxation With Representation: Baker, Simpson, Ropes - Law360
Longboard Pharmaceuticals CMO sells $983,936 in stock By Investing.com - Investing.com South Africa
Randall Kaye Sells 16,667 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Stock - MarketBeat
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc.LBPH - The Malaysian Reserve
Longboard Pharmaceuticals (NASDAQ:LBPH) Lowered to Hold at Wedbush - MarketBeat
Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52% - MSN
Lundbeck's billion-dollar acquisition will cost layoffs - MedWatch
Lundbeck to Acquire Longboard Pharmaceuticals - CHEManager
Lundbeck’s $2.6 Billion Acquisition of Longboard Pharmaceuticals - Global Legal Chronicle
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Short Interest Update - MarketBeat
Lundbeck picks up Longboard Pharmaceuticals for $2.6B - MM+M Online
Longboard Pharmaceuticals downgraded to Neutral from Buy at B. Riley - TipRanks
Longboard Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright - TipRanks
HC Wainwright Reiterates Neutral Rating for Longboard Pharmaceuticals (NASDAQ:LBPH) - MarketBeat
Longboard Pharma's Lucrative Exit To Lundbeck Another Coup For Management (NASDAQ:LBPH) - Seeking Alpha
Lundbeck Agrees To Acquire Longboard Pharmaceuticals - Contract Pharma
Longboard Pharma soars after announcing acquisition by Danish peer - Kursiv Media
Lundbeck Acquires Longboard Pharmaceuticals for $2.6 Billion - TipRanks
LBPH Stock Soars 51% as Lundbeck Acquires Longboard Pharmaceuticals for $2.6 Billion - MoneyCheck
Longboard Pharmaceuticals : Lundbeck to acquire Longboard Pharmaceuticals in a strategic deal, significantly enhancing its neuroscience pipeline Form 8 K - Marketscreener.com
Danish Lundbeck acquires American Longboard Pharmaceuticals for $2.6 billion - AK&M News
Denmark: Lundbeck to acquire Longboard Pharmaceuticals - Investors in Healthcare
Lundbeck agrees to acquire Longboard Pharma for $2.6bn - World Pharmaceutical Frontiers
Lundbeck forking out $2.6 billion to acquire Longboard Pharma | Biotechnology | The Pharmaletter - The Pharma Letter
Lundbeck to acquire Longboard Pharmaceuticals for $2.6bn - Pharmaceutical Technology
Longboard Pharmaceuticals' IPO Lock-up Period Ends On Sep. 8 - RTTNews
롱보드 파마 (LBPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
롱보드 파마 주식 (LBPH) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Kaye Randall | CMO |
Oct 15 '24 |
Sale |
59.03 |
16,667 |
983,936 |
17,920 |
Kaye Randall | CMO |
Sep 16 '24 |
Option Exercise |
4.35 |
16,666 |
72,497 |
34,586 |
Kaye Randall | CMO |
Sep 16 '24 |
Sale |
31.64 |
16,666 |
527,318 |
17,920 |
자본화:
|
볼륨(24시간):